Artwork

Indhold leveret af Drug Discovery World and Drug Discovery World (DDW). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Drug Discovery World and Drug Discovery World (DDW) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Selective Translation Regulator Inhibitors: Depriving cancer of what it needs

17:51
 
Del
 

Manage episode 415284860 series 1919400
Indhold leveret af Drug Discovery World and Drug Discovery World (DDW). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Drug Discovery World and Drug Discovery World (DDW) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Steve Worland, CEO of eFFECTOR. eFFECTOR is a company targeting three distinct targets central to the eIF4F translation initiation complex: MNK, eIF4A and eIF4E. Each of these targets regulates distinct sets of genes in cancer and immune cells.

Dr Worland has significant experience as a scientist and C-suite level executive/entrepreneur, and today speaks about how Selective Translation Regulator Inhibitors (STRIs) are unique to other cancer treatments, the future of the industry as well as the significance of pharma collaboration in the development process.

You can find the Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

  continue reading

156 episoder

Artwork
iconDel
 
Manage episode 415284860 series 1919400
Indhold leveret af Drug Discovery World and Drug Discovery World (DDW). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Drug Discovery World and Drug Discovery World (DDW) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Steve Worland, CEO of eFFECTOR. eFFECTOR is a company targeting three distinct targets central to the eIF4F translation initiation complex: MNK, eIF4A and eIF4E. Each of these targets regulates distinct sets of genes in cancer and immune cells.

Dr Worland has significant experience as a scientist and C-suite level executive/entrepreneur, and today speaks about how Selective Translation Regulator Inhibitors (STRIs) are unique to other cancer treatments, the future of the industry as well as the significance of pharma collaboration in the development process.

You can find the Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

  continue reading

156 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning